Daiichi Sankyo (United States)
Daiichi Sankyo Company, Limited is a global pharmaceutical company and the second-largest pharmaceutical company in Japan. It achieved JPY 1,278 billion in revenue in 2022. The company owns the American pharmaceutical company American Regent. Daiichi Sankyo, Inc. began operating in the U.S. in 2006. Derived from Wikipedia licensed CC-BY-SA.
Open Access statistics for Daiichi Sankyo (United States), United States, covering academic research published from 2000 to 2024. Read More.
Open Access Percentage
52%
Total
Publications
1.5K
Total Open
Publications
808
Total
Citations
48K
Open Access
Percentage
52%
Total
Publications
1.5K
Total Open
Publications
808
Total
Citations
48K
Breakdown
Publisher Open
27%
Both
20%
Other Platform Open
5%
Closed
48%
Percentage of Open Access over time
Publisher Open
Both
Other Platform Open
Closed
Volume of Open Access over time
Open
Closed
Publisher Open
OA Journal 22%
163
Hybrid 45%
326
No Guarantees 33%
236
Other Platform Open
Domain 84%
322
Institution 18%
69
Public 12%
48
Other Internet 10%
40
Preprint 8%
29
Other Platform Locations
Name | Platform Type | Publications |
|---|---|---|
PubMed Central | Domain | 320 |
Europe PMC | Domain | 125 |
DOI | Other Internet | 43 |
Semantic Scholar | Public | 36 |
Figshare | Public | 30 |
Radboud University - Radboud Repository | Institution | 14 |
Research Square | Preprint | 13 |
University College London - UCL Discovery | Institution | 11 |
Leiden University - Leiden Repository | Institution | 9 |
California Digital Library - eScholarship | Other Internet | 9 |